Aki Tomita - Sumitomo Gen Officer
SUMA Stock | EUR 20.68 0.51 2.53% |
Insider
Aki Tomita is Gen Officer of Sumitomo
Phone | 81 3 6285 5000 |
Web | https://www.sumitomocorp.com |
Sumitomo Management Efficiency
The company has return on total asset (ROA) of 0.0268 % which means that it generated a profit of $0.0268 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.18 %, meaning that it generated $0.18 on every $100 dollars invested by stockholders. Sumitomo's management efficiency ratios could be used to measure how well Sumitomo manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
Showing other executives | INSIDER Age | ||
Ash Jokhoo | Direct Line Insurance | N/A | |
Lukas CFA | Sabra Health Care | N/A | |
Michael Costa | Sabra Health Care | 43 | |
Charles Cross | Sabra Health Care | 65 | |
Charles Shaffer | Sabra Health Care | 49 | |
Willard Lee | The Hanover Insurance | 53 | |
Scott Grieco | The Hanover Insurance | N/A | |
Jessie Burrows | Direct Line Insurance | N/A | |
Michael Sonego | Sabra Health Care | N/A | |
Sarah Medina | The Hanover Insurance | N/A | |
Penelope ACA | Direct Line Insurance | 54 | |
Denise Lowsley | The Hanover Insurance | 47 | |
Lindsay Greenfield | The Hanover Insurance | N/A | |
Paul Smith | Direct Line Insurance | N/A | |
Tracey Dexter | Sabra Health Care | 49 | |
Juliette Kleffel | Sabra Health Care | 52 | |
Theodore Bunting | The Hanover Insurance | 60 | |
Talya NevoHacohen | Sabra Health Care | 62 | |
Gayle Falvey | The Hanover Insurance | N/A | |
Daniel Chappell | Sabra Health Care | N/A | |
Richard Matros | Sabra Health Care | 68 |
Management Performance
Return On Equity | 0.18 | |||
Return On Asset | 0.0268 |
Sumitomo Leadership Team
Elected by the shareholders, the Sumitomo's board of directors comprises two types of representatives: Sumitomo inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sumitomo. The board's role is to monitor Sumitomo's management team and ensure that shareholders' interests are well served. Sumitomo's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sumitomo's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hirokazu Higashino, Chief Officer | ||
Tatsuro Tamura, Corp Department | ||
Reiji Morooka, CFO Officer | ||
Yoshinori Takayama, Co Dept | ||
Koji Aso, Assistant Officer | ||
Masayuki Hyodo, CEO Pres | ||
Yasuhiro Yoshida, Assistant Department | ||
Kuniharu Nakamura, Ex Directors | ||
Takayuki Seishima, Chief Officer | ||
Aki Tomita, Gen Officer |
Sumitomo Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Sumitomo a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | 0.18 | |||
Return On Asset | 0.0268 | |||
Profit Margin | 0.09 % | |||
Operating Margin | 0.06 % | |||
Current Valuation | 37.08 B | |||
Shares Outstanding | 1.25 B | |||
Shares Owned By Insiders | 3.38 % | |||
Shares Owned By Institutions | 40.41 % | |||
Price To Earning | 5.31 X | |||
Price To Book | 0.74 X |
Currently Active Assets on Macroaxis
Other Information on Investing in Sumitomo Stock
Sumitomo financial ratios help investors to determine whether Sumitomo Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sumitomo with respect to the benefits of owning Sumitomo security.